Safe Orthopaedics S.A.
ALSAF.PA · PAR
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -21.18 | 300.93 | 0.31 |
| FCF Yield | -32.12% | -1.12% | -0.00% | -2.86% |
| EV / EBITDA | -1.02 | -101.78 | -38,804.20 | -38.03 |
| Quality | ||||
| ROIC | -8.50% | -67.13% | -80.53% | -70.55% |
| Gross Margin | 74.41% | -74.36% | -126.04% | -138.11% |
| Cash Conversion Ratio | 0.01 | 0.79 | 1.02 | 0.81 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.46% | 17.02% | -1.04% | 917.65% |
| Free Cash Flow Growth | 81.16% | 28.14% | -20.60% | -32.91% |
| Safety | ||||
| Net Debt / EBITDA | -1.01 | -1.70 | -1.53 | -0.97 |
| Interest Coverage | -36.60 | -16.79 | -11.88 | -7.74 |
| Efficiency | ||||
| Inventory Turnover | 0.35 | 2.27 | 0.54 | 0.77 |
| Cash Conversion Cycle | 671.92 | 214.49 | 607.03 | 471.25 |